
Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALS patients
Sonja Jacob, Burkhard Poeggeler, Jochen H. Weishaupt, Anna-Leena Sirén, Rüdiger Hardeland, Mathias Bähr, Hannelore EhrenreichVolume:
33
Année:
2002
Langue:
english
Pages:
2
DOI:
10.1034/j.1600-079x.2002.02943.x
Fichier:
PDF, 65 KB
english, 2002